nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Kidney Injury in Children after Hematopoietic Cell Transplantation Is Associated with Elevated Urine CXCL10 and CXCL9
|
Erez, Daniella Levy |
|
|
26 |
7 |
p. 1266-1272 |
artikel |
2 |
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices
|
Ardura, Monica |
|
|
26 |
7 |
p. e147-e160 |
artikel |
3 |
Addressing the Measles-Mumps-Rubella Revaccination Guidelines for Allogenic Bone Marrow Transplant Patients: A Response to the American Society for Transplantation and Cellular Therapy 2019 Position Statement
|
Perez, Kevin |
|
|
26 |
7 |
p. e171-e172 |
artikel |
4 |
ASTCT Notes
|
|
|
|
26 |
7 |
p. 1375-1376 |
artikel |
5 |
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
|
Bachanova, Veronika |
|
|
26 |
7 |
p. 1239-1246 |
artikel |
6 |
Clonal Evolution after Allogeneic Hematopoietic Stem Cell Transplantation: The Case of Myelofibrosis
|
Christopeit, Maximilian |
|
|
26 |
7 |
p. e167-e170 |
artikel |
7 |
Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?
|
Heelan, Francine |
|
|
26 |
7 |
p. 1298-1302 |
artikel |
8 |
Editorial Board
|
|
|
|
26 |
7 |
p. A5 |
artikel |
9 |
Favorable Effect of Cytomegalovirus Reactivation on Outcomes in Cord Blood Transplant and Its Differences Among Disease Risk or Type
|
Yokoyama, Hisayuki |
|
|
26 |
7 |
p. 1363-1370 |
artikel |
10 |
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
|
Hamadani, Mehdi |
|
|
26 |
7 |
p. 1312-1317 |
artikel |
11 |
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia
|
Eapen, Mary |
|
|
26 |
7 |
p. e161-e166 |
artikel |
12 |
Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection
|
Furfaro, Elisa |
|
|
26 |
7 |
p. 1355-1362 |
artikel |
13 |
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide
|
Mallhi, Kanwaldeep K. |
|
|
26 |
7 |
p. 1332-1341 |
artikel |
14 |
Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients
|
Corbacioglu, Selim |
|
|
26 |
7 |
p. 1342-1349 |
artikel |
15 |
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
|
Kanate, Abraham S. |
|
|
26 |
7 |
p. 1247-1256 |
artikel |
16 |
Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population
|
Bourlon, Christianne |
|
|
26 |
7 |
p. 1350-1354 |
artikel |
17 |
Masthead (Purpose and Scope)
|
|
|
|
26 |
7 |
p. A4 |
artikel |
18 |
Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India
|
Swaminathan, Venkateswaran Vellaichamy |
|
|
26 |
7 |
p. 1326-1331 |
artikel |
19 |
Officers and Directors of ASTCT
|
|
|
|
26 |
7 |
p. A6 |
artikel |
20 |
PARP Inhibition Synergizes with Melphalan but Does not Reverse Resistance Completely
|
Patel, Pritesh R. |
|
|
26 |
7 |
p. 1273-1279 |
artikel |
21 |
Priming of Allo-HLA-DP-Specific Reactivity from the Naïve T Cell Compartment Is Not Exclusively Mediated by Professional Antigen-Presenting Cells
|
Laghmouchi, Aicha |
|
|
26 |
7 |
p. 1257-1265 |
artikel |
22 |
Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them
|
Chhabra, Saurabh |
|
|
26 |
7 |
p. 1288-1297 |
artikel |
23 |
Response Improvement Rather than Response Status after First Autologous Stem Cell Transplantation Is a Significant Prognostic Factor for Survival Benefit from Tandem Compared with Single Transplantation in Multiple Myeloma Patients
|
Blocka, Joanna |
|
|
26 |
7 |
p. 1280-1287 |
artikel |
24 |
Risk Factors, Clinical Outcomes, and Cost-of-Care Related to Graft Failure in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
|
Wobma, Holly |
|
|
26 |
7 |
p. 1318-1325 |
artikel |
25 |
Securing the graft during pandemic: are we ready for cryopreservation for all?
|
Dholaria, Bhagirathbhai |
|
|
26 |
7 |
p. e145-e146 |
artikel |
26 |
Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease
|
Frairia, Chiara |
|
|
26 |
7 |
p. 1303-1311 |
artikel |
27 |
Table of Contents
|
|
|
|
26 |
7 |
p. A7-A10 |
artikel |
28 |
Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation
|
Stevens, Emily A. |
|
|
26 |
7 |
p. 1371-1374 |
artikel |